These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease. Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461 [TBL] [Abstract][Full Text] [Related]
8. [Value of lithium salts in the treatment of Huntington's chorea]. Tridon P; Arnould G; Barroche M Nouv Presse Med; 1977 Aug 27-Sep 3; 6(28):2523-4. PubMed ID: 144267 [No Abstract] [Full Text] [Related]
9. Fluoxetine-induced exacerbation of chorea in Huntington's disease? A case report. Chari S; Quraishi SH; Jainer AK Pharmacopsychiatry; 2003 Jan; 36(1):41-3. PubMed ID: 12649776 [No Abstract] [Full Text] [Related]
10. Huntington's chorea. Fisher RH; Norris JW; DeManuele F; Ridgley B; Malyon C Can Med Assoc J; 1982 Mar; 126(6):605-6. PubMed ID: 6461407 [No Abstract] [Full Text] [Related]
11. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease. Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963 [TBL] [Abstract][Full Text] [Related]
12. [The use of choline in the treatment of Huntington's chorea]. Sancesario G; Panichelli C; Bianco F; Caporali M; Piccinin GL; Stanzione P; Morocutti C Clin Ter; 1981 Feb; 96(4):393-6. PubMed ID: 6452245 [No Abstract] [Full Text] [Related]
13. [A new treatment of Huntington's chorea. Report of three cases (author's transl)]. Zenglein JP; Baldauf E; Hussaini M Sem Hop; 1978 Sep 18-25; 54(25-28):871-4. PubMed ID: 214869 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. Kumar P; Kumar A Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928 [TBL] [Abstract][Full Text] [Related]
15. The long-term effect of tetrabenazine in the management of Huntington disease. Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408 [TBL] [Abstract][Full Text] [Related]
16. Kainic acid animal model predicts therapeutic agents in Huntington's chorea. Borison RL; Diamond BI Trans Am Neurol Assoc; 1979; 104():67-9. PubMed ID: 162258 [No Abstract] [Full Text] [Related]
17. Treatment of Huntington's chorea with isoniazid. Perry TL; MacLeod PM; Hansen S N Engl J Med; 1977 Oct; 297(15):840. PubMed ID: 142923 [No Abstract] [Full Text] [Related]
18. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate]. Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166 [No Abstract] [Full Text] [Related]